Member Info for Fortnefvrsbrve

Yup another attack on 2.20

Resistance at 2.20 so good volume above that and we can see the higher heights of 2.60 for next level.

Looking good 👍

Good start

More to come 🔜

It was very predictable (even tho you can’t be for sure on aim) that it was ranging holding . And just matter of time it will start climbing up and sure did today.

Let’s see what tomorrow and this week brings :)

Very welcomed share price movements to say the least

Genedrive PLC - Manchester-based point of care pharmacogenetic testing company - Acknowledges, as announced on April 3, that the UK's National Institute for Health and Care Excellence has recommended in draft guidance that CYP2C19 genotyping should be used to guide clopidogrel use after ischaemic stroke or transient ischaemic attack, and that the Genedrive CYP2C19-ID test should be used as the test of choice for point-of-care strategies.

Https://x.com/genedriveplc/status/1805556555661853165?s=46

Genedrive will be exhibiting at #UKPGx2024in London in ONE WEEK!

🔗 Book your place: my.bps.ac.uk/events/details…

#GDR #pharmacogenetics #pharmacogenomics #POCT #PGxMovement #UKPGx #medtech #diagnostics #genetics

Https://x.com/genedriveplc/status/1803475068929839230?s=46

Https://x.com/helixexp/status/1802944334049992802?s=46

"A lot of AIM companies are quite happy to throw around large discounted fundraises.

#HEX is not one of them.

There is a range of options available to finance this project without having to go for large-scale dilution."

Chairman David Minchin

Https://x.com/helixexp/status/1802643590662762858?s=46

Https://x.com/helixexp/status/1801132391450223015?s=46

Https://x.com/helixexp/status/1800824770205806922?s=46

Https://x.com/helixexp/status/1800465566907482568?s=46

Https://x.com/share_talk/status/1800430515985731776?s=46

***

Indeed, it looks as though the shares are only just getting started given today’s news.

***

Comment: The low CAPEX here is certainly a wow, and explains why shares of HEX are already 2.5x since IPO, and of course why the IPO had to be so heavily scaled back. Indeed, it looks as though the shares are only just getting started given today’s news.

Helix Exploration (HEX), the helium exploration and development company focused on helium deposits within the ‘Montana Helium Fairway’, announced the results of a Scoping Study Economic Analysis conducted by Aeon Petroleum Consultants Corporation. Highlights included: NPV8 of $303.1 million using a helium price of $550/Mcf and grade of 1.50%. Initial CAPEX requirement of only $19.7 million. Net revenue of $605.6 million. HEX said the Ingomar Dome Project demonstrates potentially high returns and low capital requirements. Rapid payback and free cash-flow estimates of over $40 million dollars a year release a range of finance possibilities to provide initial CAPEX requirement.

Https://x.com/helixexp/status/1800411051768336572?s=46

Https://x.com/share_talk/status/1799807435626160441?s=46

Https://x.com/helixexp/status/1798958078177812774?s=46

Https://x.com/helixexp/status/1797553565336059986?s=46

#HEX is pleased to share an article written by our CEO Bo Sears in which he talks about the soaring #Helium demand, driving prices to record highs.

"Outdated contracts are costing the U.S. gov & taxpayers tens of millions annually in lost royalties."